Bariatric surgery compared to non-surgical treatment was associated with a reduced risk of incident heart failure in obese patients (pooled multivariable HR 0.44; 95% CI 0.36-0.55).
Meta-Analysis (n=111,803)
Does bariatric surgery prevent incident heart failure or improve outcomes in obese patients with or without prevalent heart failure compared to non-surgical treatment?
Bariatric surgery may prevent incident heart failure in obese patients, though high-quality randomized data in patients with established heart failure is lacking.
Effect estimate: HR 0.44 (95% CI 0.36-0.55)
Background: Bariatric surgery reduces cardiovascular risk in obese patients. Heart failure (HF) is associated with an increased perioperative risk following bariatric surgery. This systematic review aimed to assemble the evidence on bariatric surgery in patients with known HF and the potential effect of bariatric surgery on incident HF in obese patients without prevalent HF. Methods: We performed a comprehensive literature search up to 30 September 2017 and included studies comparing bariatric surgery to non-surgical treatment in patients with known presurgical HF. To assess whether bariatric surgery has any effect on incident HF, we also assembled studies looking at new-onset HF among patients without HF prior to surgery. Results: We found five observational studies (0 randomised trials) comparing bariatric surgery with non-surgical treatment in patients with a diagnosis of HF prior to surgery. A review of the available studies (n=676 patients) suggested reduced admission rates for HF exacerbation and increased left ventricular ejection fraction after bariatric surgery. No meta-analysis was possible due to the heterogeneous nature of these studies. Seven studies (one randomised trial) reported data on new-onset HF in obese patients without HF prior to bariatric surgery (n=111 127 patients). When comparing surgical to non-surgical treatment groups, the pooled univariable and multivariable HRs for incident HF were 0.28 (95% CI 0.13 to 0.55) and 0.44 (95% CI 0.36 to 0.55), respectively. Conclusion: In this systematic review, no randomised trial assessed the benefits and risks of bariatric surgery in obese patients with concomitant HF. Available studies do, however, show that surgery might prevent incident HF.
Berger et al. (Sat,) conducted a meta-analysis in Obesity and Heart Failure (n=111,803). Bariatric surgery vs. Non-surgical treatment was evaluated on Incident heart failure (new-onset HF) (HR 0.44, 95% CI 0.36-0.55). Bariatric surgery compared to non-surgical treatment was associated with a reduced risk of incident heart failure in obese patients (pooled multivariable HR 0.44; 95% CI 0.36-0.55).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: